Company profile: Catalyst Clinical Research
1.1 - Company Overview
Company description
- Provider of clinical operation solutions to biotechnology, pharmaceutical, and medical device companies, built on over two decades of experience supporting clinical development with therapeutically aligned experts and customized solutions. Offers Catalyst Oncology, a full-service CRO for cancer drug development, and Catalyst Flex, FSP services in clinical operations, data management, biostatistics, programming, safety, and medical writing.
Products and services
- Customized Clinical Development Support: Assists biotechnology, pharmaceutical, and medical device clients by deploying therapeutically-aligned experts and teams and tailoring clinical development programs—custom-engineered, client-specific approaches
- Catalyst Oncology: Full-service oncology clinical research organization that engineers comprehensive support for cancer drug development—therapeutically-aligned expertise focused specifically on oncology programs
- Catalyst Flex: Delivers specialized functional service provider systems across multiple therapeutic areas—clinical operations, data management, biostatistics, programming, safety, and medical writing—modular.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Catalyst Clinical Research
NeuroTrax
HQ: United States
Website
- Description: Provider of BrainCare, a cloud-based brain wellness assessment platform offering tests across seven cognitive areas, graphical reports for clinicians to track baselines and progress, and personalized activity and brain training recommendations, plus a 30-minute Post COVID Testing Suite evaluating memory, executive function, attention, and information processing speed for post-COVID cognitive assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroTrax company profile →
Argot Partners
HQ: United States
Website
- Description: Provider of corporate and financial communications consultancy services to public and private companies, investment funds, and high net worth individuals, leveraging broad agency and industry experience to address challenges facing growing companies and those in distress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Argot Partners company profile →
Argon Network
HQ: United Kingdom
Website
- Description: Provider of an international network of independent healthcare agencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Argon Network company profile →
Absorption Systems
HQ: United States
Website
- Description: Provider of research tools developed and implemented to help customers better predict human outcomes, serving a wide variety of pharmaceutical and biotech industry customers, including small virtual pharma companies; with locations in Exton, Pennsylvania; San Diego, California; and Panama City, Panama.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Absorption Systems company profile →
Siegfried
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siegfried company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Catalyst Clinical Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Catalyst Clinical Research
2.2 - Growth funds investing in similar companies to Catalyst Clinical Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Catalyst Clinical Research
4.2 - Public trading comparable groups for Catalyst Clinical Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →